Establishment Labs Holdings (ESTA) Net Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 67.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.96% |
| Dec 31, 2025 | -91.85% |
| Sep 30, 2025 | 206.49% |
| Jun 30, 2025 | 13.60% |
| Mar 31, 2025 | -166.93% |
| Dec 31, 2024 | 508.75% |
| Sep 30, 2024 | 59.46% |
| Jun 30, 2024 | -138.48% |
| Mar 31, 2024 | 240.31% |
| Dec 31, 2023 | -2,483.30% |
| Sep 30, 2023 | -47.40% |
| Jun 30, 2023 | 0.06% |
| Mar 31, 2023 | -166.87% |
| Dec 31, 2022 | 104.79% |
| Sep 30, 2022 | -114.48% |
| Jun 30, 2022 | 3,660.30% |
| Mar 31, 2022 | -41.02% |
| Dec 31, 2021 | -490.34% |
| Sep 30, 2021 | -132.90% |
| Jun 30, 2021 | 81.88% |
| Mar 31, 2021 | -111.21% |
| Dec 31, 2020 | 156.73% |
| Sep 30, 2020 | -147.19% |
| Jun 30, 2020 | 35.29% |
| Mar 31, 2020 | 693.25% |
| Dec 31, 2019 | 61.30% |
| Sep 30, 2019 | -80.03% |
| Jun 30, 2019 | -324.88% |
| Mar 31, 2019 | -117.03% |
| Dec 31, 2018 | -317.42% |
| Sep 30, 2018 | 1,312.71% |